Drug Shortage Report for M-LANSOPRAZOLE

Last updated on 2020-12-12 History
Report ID 123497
Drug Identification Number 02489805
Brand name M-LANSOPRAZOLE
Common or Proper name M-Lansoprazole (15 mg)
Company Name MANTRA PHARMA INC
Market Status MARKETED
Active Ingredient(s) LANSOPRAZOLE
Strength(s) 15MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-08-24
Estimated end date 2020-12-28
Actual end date 2020-12-11
Shortage status Resolved
Updated date 2020-12-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1000 RUE DU LUX SUITE 201
BROSSARD, QUEBEC
CANADA J4Y 0E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2020-12-12 English Compare
v23 2020-12-11 French Compare
v22 2020-12-11 English Compare
v21 2020-12-11 French Compare
v20 2020-12-11 English Compare
v19 2020-12-11 French Compare
v18 2020-12-11 English Compare
v17 2020-12-11 French Compare
v16 2020-12-11 English Compare
v15 2020-12-11 French Compare
v14 2020-12-11 English Compare
v13 2020-12-11 French Compare
v12 2020-12-11 English Compare
v11 2020-12-11 French Compare
v10 2020-12-11 English Compare
v9 2020-12-11 French Compare
v8 2020-12-11 English Compare
v7 2020-11-20 French Compare
v6 2020-11-20 English Compare
v5 2020-10-23 French Compare

Showing 1 to 20 of 24